BioSpace News Archive

GT Biopharma, Inc. an immuno-oncology company focused on innovative treatments based on the Company’s proprietary NK cell engager platform and Multi-Target Directed Bispecific Drug Conjugate platform, provided an update of the company’s drug development programs.

The fasting growing supplement company partners with iconic social media star and fitness advocate, Jen Selter

Grassroots nurses group says legislation is needed to reduce patient pain and suffering from repeated needlesticks

In Conjunction with A Week to Change Direction, Weekly Series to Air on YouTube

First Commercial Patient Prescribed with the ZOLL µCor Heart Failure and Arrhythmia Management System

PTSD Foundation of America to launch a Nationwide Awareness Campaign

The research findings were presented on June 8, 2019 at the American Diabetes Association’s 79th Scientific Sessions held in San Francisco, California.

In recognition of International NASH Day, June 12, 2019, leading stakeholders in preventing liver disease call for increased vigilance regarding early detection of non-alcoholic fatty liver disease (NAFLD) and its subtype non-alcoholic steatohepatitis (NASH), a potentially progressive liver disease that can lead to cirrhosis, hepatocellular carcinoma (HCC), liver cancer, liver transplantation and death

Common concentration now available exclusively in FDA-approved ready-to-administer prefilled syringe

Mimedx Shareholder Group issued the following statement to fellow shareholders of Mimedx Group, Inc.